Last reviewed · How we verify
NCT03372902
Development Of A Blood Test To Improve The Performance Of Breast Cancer Screening
trial testing Breast MRI in Breast Cancer in 628 participants. Completed in 12 March 2025.
12 March 2025
Quick facts
| Lead sponsor | Memorial Sloan Kettering Cancer Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 628 |
| Start date | 7 December 2017 |
| Primary completion | 12 March 2025 |
| Estimated completion | 12 March 2025 |
| Sites | 7 locations across United States |
Drugs / interventions tested
- Breast MRI
- Breast Mammogram
- Blood draw — full drug profile →
- Breast Biopsy
- online participant reported questionnaire
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
- Breast Benign — all drugs for Breast Benign →
Sponsor
Memorial Sloan Kettering Cancer Center — full company profile →
Who can join
18 and older, female only, with Breast Cancer or Breast Benign. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to collect blood and tissue to help develop tests that might be able to detect cancer earlier. The investigator will be collecting these samples and reviewing test results from participants who have had an area of concern found on breast imaging, as well as from participants who are scheduled to have a routine breast cancer screening mammogram.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The breast is yet to come: current and future utility of circulating tumour DNA in breast cancer.
Davidson BA, Croessmann S, Park BH. · · 2021 · cited 20× · PMID 34040179 · DOI 10.1038/s41416-021-01422-w
Verify or expand the search:
- PubMed search for NCT03372902
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Breast MRI
Trials testing the same drug.
- NCT05990478 — A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer · withdrawn
- NCT04871516 — Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer · NA · active not recruiting
- NCT05825768 — Preoperative Magnetic Resonance Imaging to Obtain Adequate Resection Margins in Breast Conserving Surgery, (PRIMAR) Tria · NA · terminated
- NCT04468867 — Role of ABUS as an Alternative to Breast MRI in Assessing Response to Neoadjuvant Chemotherapy · NA · unknown
- NCT03870659 — Abbreviated Breast MRI in Cancer Detection · completed
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other Memorial Sloan Kettering Cancer Center trials
Trials by the same sponsor.
- NCT07566377 — Cord Blood Transplantation in Children and Young Adults With Blood Cancer · Phase 2 · recruiting
- NCT07507643 — A Study of Methylprednisolone in People Having Liver Surgery · Phase 3 · recruiting
- NCT07483307 — A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer · Phase 2 · recruiting
- NCT07459673 — HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term · Phase 2 · recruiting
- NCT07449195 — A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03372902 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center
- Last refreshed: 14 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03372902.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing